摘要
目的观察它莫西芬配合金施尔康、肾气丸治疗少弱精子性不育的疗效。方法120例少弱精子症患者分为两组,治疗组口服它莫西芬、金施尔康和肾气丸,对照组口服维生素E,6个月后复查精液和血清性激素。结果治疗后精子密度、精子质量显著改善,血清FSH、LH、T均明显升高,PRL、E2无明显变化,所有患者均无不良反应发生;对照组精液参数和血清生殖激素均无明显变化。结论它莫西芬配合金施尔康、肾气丸是治疗少弱精子症的安全、有效方法。
Objective To estimate the effect of tamoxifen, Golden Theragpam and Shenqi Pills in the threatment of oligoasthenozoospermia. Methods 120 patients with oligoasthenozoospermia were divided into the treatment group and control group. The treatment group took tamoxifen, Golden Theragpam and Shenqi Pills. The control group took VitE. The seminal routine analysis were performed by computer assisted sperm analysis （CASA） and the sexual hormone in serum were detected respectively by chemical luminescence technique at the end of 6 months. Results In treatment group, the sperm density and sperm quality were improved significantly. The values of FSH, LH and T were significantly raised and there was no significant difference in the values of PRL and E2.All of patients had not any side-effects. All parameters of sperm and sexual hormone in serum were not significantly different in the control group. Conclusion Treating o ligoasthenozoospermia with tamoxifen, Golden Theragpam and Shenqi Pills is safe and effective.
出处
《现代泌尿外科杂志》
CAS
2009年第1期32-34,共3页
Journal of Modern Urology
关键词
不育症
治疗
它莫西芬
金施尔康
肾气丸
infertility
treatment
tamoxifen
Golden Theragpam
Shenqi Pills
